Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?
11:07am, Thursday, 25'th Jul 2024
Sensus Healthcare (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recent Price Trend in Sensus Healthcare (SRTS) is Your Friend, Here's Why
09:50am, Thursday, 25'th Jul 2024
Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro
3 Stocks in Focus as New Analysts Initiate Coverage
10:05am, Tuesday, 23'rd Jul 2024
The recent surge in analyst coverage for stocks such as BrightSphere (BSIG), Sensus Healthcare (SRTS) and ServisFirst (SFBS) indicates the potential for significant price appreciation in the near term
Sensus Healthcare (SRTS) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Friday, 19'th Jul 2024
Sensus Healthcare (SRTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
07:21pm, Tuesday, 16'th Jul 2024
Sensus Healthcare, Inc. (SRTS) closed at $5.99 in the latest trading session, marking a -0.66% move from the prior day.
Sensus Healthcare (SRTS) Is a Great Choice for 'Trend' Investors, Here's Why
09:51am, Tuesday, 09'th Jul 2024
Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thro
Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why
07:21pm, Tuesday, 25'th Jun 2024
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
07:20pm, Monday, 17'th Jun 2024
Sensus Healthcare, Inc. (SRTS) closed at $5.22 in the latest trading session, marking a -1.51% move from the prior day.
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
07:20pm, Monday, 10'th Jun 2024
Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $5.48, signifying a -0.54% move from its prior day's close.
Sensus Healthcare, Inc. (SRTS) Crossed Above the 20-Day Moving Average: What That Means for Investors
10:36am, Tuesday, 04'th Jun 2024
Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SRTS crossed above the 20-day moving average,
Here's Why Momentum in Sensus Healthcare (SRTS) Should Keep going
09:50am, Friday, 31'st May 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare (SRTS) could be a great choice. It is one of the several stocks that passed through our "Rece
Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year?
10:40am, Thursday, 30'th May 2024
Here is how Sensus Healthcare, Inc. (SRTS) and Aileron Therapeutics, Inc. (ALRN) have performed compared to their sector so far this year.
5 Stocks With Recent Price Strength That Have More Upside Left
08:51am, Wednesday, 29'th May 2024
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SRTS, DBD, ATGE, DY, SGC.
Sensus Healthcare, Inc. (SRTS) Q1 2024 Earnings Call Transcript
11:32am, Saturday, 11'th May 2024
Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA, IR Joe Sardano - Chairman and CEO Michael Sardano - President an
Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold
04:05pm, Thursday, 09'th May 2024
Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; A djusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year quarter La
